Caldera Medical has announced the acquisition of UVision360, developer of the LUMINELLE hysteroscopy and cystoscopy systems. The deal expands Caldera’s portfolio in minimally invasive solutions for diagnosing and treating conditions such as polyps, fibroids, and intrauterine pathology.
“We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio,” said Bryon Merade, CEO of Caldera Medical. “This acquisition strengthens our commitment to offering gynecologic surgeons state-of-the-art tools that streamline hysteroscopic procedures while enhancing patient safety and clinical outcomes.”
The LUMINELLE system combines high-resolution optics with operational simplicity, providing a cost-effective option for both diagnostic and therapeutic hysteroscopy. The system’s compatibility with existing surgical workflows makes it particularly relevant for gynecologic surgeons seeking efficient, minimally invasive solutions.
Erich Dreyer, co-founder and engineer behind the LUMINELLE technology, will join Caldera Medical. “I’m thrilled to join the talented team at Caldera Medical to expand the commercial reach of the LUMINELLE portfolio. I’m particularly excited about our new LUMINELLE Bx product, which allows physicians to achieve a more accurate and precise diagnosis through its novel on-demand biopsy technology with integrated visualization. With Caldera’s commercial infrastructure and investment in women’s health, we will be able to provide both physicians and patients with a solution to the flawed uterine disease diagnosis market dominated by inaccurate blind biopsies.”
“The LUMINELLE team has worked diligently to finally provide an accurate and easy diagnosis to a growing deadly disease, Uterine Cancer,” said Allison London Brown, CEO and co-founder of LUMINELLE. “We are excited that Caldera Medical shares our vision and will accomplish this mission.”
The acquisition combines Caldera Medical’s Benesta product line with the LUMINELLE system, aiming to improve clinical outcomes for intrauterine treatments in both office-based and surgical settings. These procedures include polypectomies, biopsies, and fibroid resections.
